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Summary
Biosynthesis of the nucleotide sugar precursor 
dTDP-L-rhamnose is critical for the viability and viru-
lence of many human pathogenic bacteria, including 
Streptococcus pyogenes (Group A Streptococcus; 
GAS), Streptococcus mutans and Mycobacterium 
tuberculosis. Streptococcal pathogens require 
dTDP-L-rhamnose for the production of structurally 
similar rhamnose polysaccharides in their cell wall. 
Via heterologous expression in S. mutans, we con-
firmed that GAS RmlB and RmlC are critical for 
dTDP-L-rhamnose biosynthesis through their action 
as dTDP-glucose-4,6-dehydratase and dTDP-4-keto-
6-deoxyglucose-3,5-epimerase enzymes respec-
tively. Complementation with GAS RmlB and RmlC 
containing specific point mutations corroborated 
the conservation of previous identified catalytic resi-
dues. Bio-layer interferometry was used to identify 
and confirm inhibitory lead compounds that bind to 
GAS dTDP-rhamnose biosynthesis enzymes RmlB, 
RmlC and GacA. One of the identified compounds, 
Ri03, inhibited growth of GAS, other rhamnose-
dependent streptococcal pathogens as well as M. 
tuberculosis with an IC50 of 120–410 µM. Importantly, 
we confirmed that Ri03 inhibited dTDP-L-rhamnose 
formation in a concentration-dependent manner 
through a biochemical assay with recombinant 
rhamnose biosynthesis enzymes. We therefore con-
clude that inhibitors of dTDP-L-rhamnose biosynthe-
sis, such as Ri03, affect streptococcal and 
mycobacterial viability and can serve as lead com-
pounds for the development of a new class of antibi-
otics that targets dTDP-rhamnose biosynthesis in 
pathogenic bacteria.
Introduction
The typical cell wall architecture of a Gram-positive bac-
terium consists of a thick peptidoglycan layer that is dec-
orated with wall teichoic acids, proteins and capsular 
polysaccharides. However, certain lactic acid bacteria, 
particularly streptococcal species, lack the expression of 
wall teichoic acids and instead express rhamnose cell wall 
polysaccharides, which are covalently anchored to pepti-
doglycan (Mistou et al., 2016). Rhamnose cell wall poly-
saccharides encompass about 40–60% of the cell wall 
mass and are considered to be functional homologs of wall 
teichoic acids (Sutcliffe et al., 2008; Caliot et al., 2012). 
Examples of rhamnose cell wall polysaccharides are the 
group A carbohydrate (GAC) of Group A Streptococcus 
(GAS; Streptococcus pyogenes) and the serotype-deter-
mining polysaccharides, referred to as rhamnose-glucose 
polysaccharides (RGP), of Streptococcus mutans. The 
GAC and RGP share structural similarities; both consist 
of an α-1,2-/α-1,3-linked polyrhamnose backbone with 
alternating N-acetylglucosamine side chains for GAS and 
glucose or galactose side chains for S. mutans (Heymann 
et al., 1964; Linzer et al., 1985; Huang et al., 1986; 
Pritchard et al., 1986; St Michael et al., 2017) (Fig. 1). 
For S. mutans, the type of side chain as well as their link-
age to the rhamnan backbone determines the S. mutans 
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serotype (Nakano and Ooshima, 2009; St Michael et al., 
2017) (Fig. 1). In contrast, all GAS serotypes express a 
structurally invariant GAC (Lancefield, 1933). Similar to 
classical wall teichoic acids, rhamnose cell wall polysac-
charides are critical for maintaining cell shape, bacterial 
physiology and virulence, but in-depth knowledge of their 
biosynthesis or host interactions at a molecular level is 
limited (van Sorge et al., 2014; van der Beek et al., 2015; 
Kovacs et al., 2017; Zhu et al., 2017). A better under-
standing of these mechanisms could aid the development 
of new classes of antibiotics, antibiotic adjuvants or vac-
cines (Sabharwal et al., 2006; van Sorge et al., 2014; St 
Michael et al., 2017).
L-Rhamnose is the main building block for both the 
GAC and RGP. The biosynthesis pathway of the nucle-
otide precursor, dTDP-L-rhamnose, is highly conserved 
among both Gram-positive and Gram-negative bacteria 
(Giraud and Naismith, 2000; Mistou et al., 2016) and crit-
ical or even essential for viability or virulence of a wide 
range of human pathogens including GAS (Le Breton 
et al., 2013; 2015), Group B Streptococcus (GBS) (Caliot 
et al., 2012; Hooven et al., 2016), some serotypes of 
Streptococcus pneumoniae (Kim et al., 1999; Magee and 
Yother, 2001), S. mutans (Tsuda et al., 2000; Engels-
Deutsch et al., 2003; Kovacs et al., 2017; Shields et al., 
2018), Enterococcus faecalis (Xu et al., 2000; Rigottier-
Gois et al., 2015), Mycobacterium spp. (Ma et al., 2002; 
Li et al., 2006), Pseudomonas spp. (Engels et al., 1985) 
and Salmonella enterica serovar Typhimurium (Joiner, 
1988). Consequently, this pathway is considered to 
be an interesting drug target, especially since dTDP- 
L-rhamnose is not produced or used by humans (Adibekian 
et al., 2011).
dTDP-L-rhamnose is produced through a four-step enzy-
matic pathway catalyzed by the enzymes RmlABCD. In 
the first step of the pathway, RmlA, a glucose-1-phosphate 
thymidyltransferase, converts glucose-1-phosphate into 
dTDP-glucose (Blankenfeldt et al., 2000), which is subse-
quently oxidized and dehydrated to form dTDP-4-keto-6-
deoxy-D-glucose by the dTDP-D-glucose 4,6-dehydratase 
RmlB (Beis et al., 2003). RmlC catalyzes an unusual dou-
ble epimerization reaction (Giraud et al., 2000; Dong et 
al., 2003b; 2007), the product of which is finally reduced 
by RmlD, a dTDP-4-dehydrorhamnosereductase, to form 
dTDP-L-rhamnose (Blankenfeldt et al., 2002; van der 
Beek et al., 2015). The mechanisms of action as well as 
structural characteristics of the RmlABCD enzymes have 
been studied extensively (Blankenfeldt et al., 2000; Giraud 
and Naismith, 2000; Allard et al., 2001; Beis et al., 2003; 
Dong et al., 2003a; 2003b; Kantardjieff et al., 2004; van 
der Beek et al., 2015). Indeed, crystal structures are avail-
able for all four Rml enzymes from different Gram-positive 
and Gram-negative bacterial species and show high struc-
tural conservation. This structural and functional informa-
tion has enabled the development of different screening 
methods to discover inhibitors against RmlBCD, yielding 
compounds that can inhibit dTDP-L-rhamnose biosynthe-
sis in the low micromolar range (1–100 µM) in biochemi-
cal assay and inhibit growth of Mycobacterium in vitro (Ma 
et al., 2001; Babaoglu et al., 2003; Sivendran et al., 2010; 
Wang et al., 2011; Ren et al., 2015). Many of the identified 
compounds have limited solubility in aqueous solutions. 
Therefore, further biochemical and structural information 
on this pathway in additional species is important to opti-
mize lead compounds for improved affinity and specificity 
through rational design.
Fig. 1. Schematic overview of streptococcal rhamnose polysaccharide structures. Schematic representation of the chemical composition 
of the GAC from GAS and the serotype-specific (c, e, f and k) carbohydrates from S. mutans (SMU). All carbohydrates share an α-1,2/α-1,3 
linked polyrhamnose backbone. Sugar residues in dashed boxes were recently identified by St Michael et al. (2017).
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Recently, we characterized GAS GacA as a RmlD 
homolog catalyzing the last step in dTDP-L-rhamnose 
biosynthesis (van der Beek et al., 2015). Surprisingly, 
this GAS RmlD enzyme was confirmed to be a mono-
mer as opposed to previously characterized RmlD 
dimers. Additional bioinformatics analysis of 213 RmlD 
homologs revealed that the majority of RmlD enzymes 
are predicted to be monomeric, while only a subclass 
of RmlD enzymes in Gram-negatives form metal-de-
pendent homodimers (Blankenfeldt et al., 2002). In 
this study, we extended our work to study GAS RmlB 
and RmlC on a functional level through heterologous 
expression in S. mutans and subsequent analysis of 
growth, morphology and cell wall composition. In addi-
tion, we report the identification of small chemical frag-
ments that bind these enzymes and inhibit GAS growth 
with IC50s ranging from 100 to 300 µM (Ri01, Ri02, Ri03 
and Ri06) to 2.7 mM (Ri08). For one compound, Ri03, 
we confirmed inhibition of dTDP-L-rhamnose in a bio-
chemical assay. Furthermore, Ri03 could inhibit growth 
of S. mutans, S. equi subsp. zooepidemicus (Group C 
Streptococcus, GCS) and Mycobacterium tuberculosis 
with similar efficacy. These results demonstrate that 
rhamnose biosynthesis inhibitors can directly interfere 
with bacterial viability and could form a new class of 
antibiotics targeting nucleotide sugar production.
Results
GAS RmlB and RmlC functionally replace S. mutans 
homologs
As an extension of our previous work on GAS GacA 
(van der Beek et al., 2015), we sought to characterize 
GAS RmlB (GAS5448_RS05645) and RmlC (GAS5448_
RS05650), the putative dTDP-glucose-4,6-dehydratase 
and dTDP-4-keto-6-deoxyglucose-3,5-epimerase 
respectively. GAS rmlB and rmlC are clustered in an 
operon together with rmlA in the order rmlACB. Structural 
and biochemical analysis of RmlB and RmlC from 
Streptococcus suis, S. enterica and M. tuberculosis 
revealed that both enzymes are functional homodimers 
in these organisms (Giraud et al., 2000; Allard et al., 
2001; Beis et al., 2003; Dong et al., 2003b; Kantardjieff 
et al., 2004). Protein sequence alignment of RmlB and 
RmlC homologs from several streptococcal species and 
S. enterica displayed high homology (Fig. 2, Table S2). 
Importantly, all catalytic residues in RmlB and RmlC are 
conserved (Fig. 2, Table S2).
Most genes directly or indirectly involved in the GAC 
biosynthesis pathway are essential for GAS viability, 
including all four dTDP-L-rhamnose biosynthesis genes 
rmlABC and gacA (Le Breton et al., 2013; 2015; van der 
Beek et al., 2015; Zhu et al., 2017). In contrast and for 
unknown reasons, the dTDP-L-rhamnose biosynthesis 
genes are not essential in S. mutans under noncompeti-
tive conditions. However, gene deletions result in strongly 
attenuated growth and severe morphological defects 
(Tsukioka et al., 1997; van der Beek et al., 2015). GAS 
RmlB and RmlC proteins share 94% and 83% protein 
sequence identity with their S. mutans homologs respec-
tively. In addition, the organization of these genes is 
identical in both species with the exception of a hypothet-
ical protein (174 nucleotides, 57 amino acids) encoded 
between RmlC and RmlB.
We took advantage of the nonessential nature of the 
rhamnose biosynthesis genes in S. mutans to confirm 
the function of GAS RmlB and RmlC in dTDP-L-rham-
nose biosynthesis. To this end, GAS RmlB and GAS 
RmlC-encoding genes were heterologously expressed in 
S. mutans strains lacking rmlB or rmlC respectively. 
Deletion of S. mutans rmlB (SMU ΔrmlB) or rmlC (SMU 
ΔrmlC) by replacement with an erythromycin resistance 
cassette severely attenuated bacterial growth compared to 
the wild-type strain (WT) (Fig. 3). This phenotype is char-
acteristic for a rhamnose-deficient S. mutans strain and in 
line with our previously constructed S. mutans rmlD dele-
tion strain (van der Beek et al., 2015). Morphological anal-
ysis of rmlB and rmlC mutant bacteria by scanning electron 
microscopy revealed swelling and clumping of bacteria as 
a result of misplaced septa resulting in division errors and 
multidirectional growth (Fig. 4A). Subsequent analysis of 
the cell wall carbohydrate composition by HPLC/MS con-
firmed that SMUΔrmlB and SMUΔrmlC lacked rhamnose 
in their cell walls, which concordantly resulted in the loss 
of the glucose side chains (Fig. 4B). Introduction of either 
homologous S. mutans rmlB or heterologous GAS rmlB on 
an expression plasmid in the corresponding SMU ΔrmlB 
mutant restored rhamnose incorporation in the cell wall 
(Fig. 4B) as well as the defective morphological pheno-
type and growth (Figs 3 and 4A). Initially, we were unable 
to complement SMUΔrmlC with rmlC from S. mutans, 
whereas heterologous GAS rmlC could restore growth, 
morphology and rhamnose production of the SMUΔrmlC 
mutant (Figs 3B and 4). Upon reexamination of the UA159 
genome, a S. mutans serotype c strain that we used as a 
reference genome for S. mutans Xc, we located an alterna-
tive ATG-start site 135 bp upstream of the annotated rmlC 
gene, which is in line with the annotation of rmlC in GAS. 
Importantly, available structural information indicates that 
the first 45 amino acids are part of the RmlC dimerization 
interface, forming the extension of the beta-sheet with two 
additional beta-strands, which are required for nucleotide 
binding (Christendat et al., 2000; Giraud and Naismith, 
2000). In agreement with structural and genetic predic-
tions, complementation of SMU ΔrmlC with the extended 
PCR product complemented all observed defects (Figs 3B 
and 4), indicating that the extended genomic PCR product 
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Fig. 2. Protein sequence alignment and identity matrix of RmlB and RmlC homologs. Color-coded representation of amino acid conservation 
for (A) GAS RmlB and (B) GAS RmlC to S. enterica and different streptococcal species. The amino acid conservation is scored from 0 to 10, 
with 0 (color blue) assigned to the least conserved residue and 10 (color red) to the most conserved residue. Critical enzymatic residues for 
RmlB (Y159) and RmlC (H76 and K82) are indicated with an inverted triangle. S. pyogenes (Spyo); Salmonella enterica; (Sent); S. agalactiae 
(Saga); Streptococcus anginosus (Sang); Streptococcus dysgalactiae (Sdys); Streptococcus equi (Sequ); Streptococcus equinus (Seqn);  
S. mutans (Smut); S. pneumoniae (Spneu); Streptococcus suis (Ssui). Protein accession numbers are described in the supplementary data 
(Table S2). C. Percentage identity matrix of RmlB and RmlC homologs.
Function and inhibition of dTDP-L-rhamnose enzymes 5
© 2019 The Authors. Molecular Microbiology Published by John Wiley & Sons Ltd, Molecular Microbiology, 0, 1–14
encodes a functional RmlC enzyme (198 amino acids), 
which is similar to the size of GAS and S. suis RmlC (197 
amino acids).
Catalytic residues of GAS RmlB and RmlC are 
conserved
Based on the conformation of catalytic residues in 
S. suis RmlB and RmlC (Allard et al., 2001; Dong et al., 
2003b) and protein sequence alignment with the GAS 
RmlB and RmlC homologs (Fig. 2), we set out to func-
tionally validate predicted catalytic residues of GAS 
RmlB (Y159) and RmlC (H76 and K82). Point mutations 
were individually introduced in GAS RmlB (Y159F) and 
RmlC (H76N and K82A) and overexpression vectors 
carrying these mutant genes were expressed in SMU 
ΔrmlB and SMUΔrmlC respectively. The residues that 
were mutated are all important for enzymatic activity, 
since the mutated genes were unable to complement 
the characteristic rhamnose-depleted phenotype con-
sisting of growth retardation and an aberrant mor-
phology (Figs 3 and 4A). Correspondingly, our cell 
wall composition analysis revealed that the S. mutans 
strains carrying these three mutated constructs com-
pletely lacked incorporation of rhamnose in their cell 
wall (Fig. 4B). The functional characterization and 
confirmation of catalytic residues of streptococcal 
RmlB and RmlC is important for identification, charac-
terization and optimization of potential dTDP-L-rham-
nose biosynthesis inhibitors through a rational design 
approach.
Inhibitor screen against GAS Rml proteins and hit 
confirmation
Given the importance of the dTDP-L-rhamnose biosyn-
thesis pathway for viability or virulence of many human 
pathogens, we aimed to identify chemical scaffolds 
that could act as starting points for future optimization 
and drug development. In addition, such compounds 
could also find applications in chemical biological stud-
ies aimed at understanding the biosynthesis of dTDP-
L-rhamnose, particularly when a genetic approach is 
not possible or desired. Therefore, we conducted a 
bio-layer interferometry (BLI) inhibitor screen against 
the commercially available Maybridge Library using 
the three recombinant GAS dTDP-rhamnose biosyn-
thesis enzymes RmlB, RmlC and GacA (Fig. S1A). 
The advantage of this approach is that it precludes the 
use of expensive or commercially unavailable enzyme 
Fig. 3. Heterologous expression of GAS RmlB and RmlC and catalytically inactive enzymes in S. mutans: growth curves. Growth curves of 
S. mutans (A) rmlB and (B) rmlC mutant sets: wild type (WT), ΔrmlB, ΔrmlC, ΔrmlB + pSB, ΔrmlB + pGB(_Y159F), ΔrmlC + pSC and ΔrmlC + 
pGC(_H76N/K82A). Growth curves represent mean ± standard error of mean (SEM) of at least three biological repeats.
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substrates. Using a commercially available library of 
~1,000 chemical fragments, our initial screen identi-
fied 12 hits (Figs 5, S1B-D) of which seven fragments 
were found to specifically interact with GAS RmlB/
RmlC/GacA as confirmed by BLI (Figs 5, S2). In addi-
tion, we confirmed the identified hits in dilution series 
for their binding affinity to these three enzymes (Fig. 
S2). Importantly, this method allowed us to estimate 
enzyme specificity by comparing the data obtained 
from one enzyme to the other two. Using this strategy, 
we identified chemical scaffolds with specificity for one 
enzyme, but also several fragments that bound to more 
than one enzyme of the dTDP-rhamnose biosynthesis 
pathway (Figs 5, S2, and Table 1).
Bactericidal activity of identified fragments
Since dTDP-rhamnose is an essential nucleotide sugar in 
GAS (Le Breton et al., 2013; 2015), we assessed whether 
these fragments could affect GAS growth. All fragments 
Fig. 4. Heterologous expression of GAS RmlB and RmlC and catalytically inactive enzymes in S. mutans: morphology and cell wall content. 
A. Representative scanning electron microscopy images and (B) cell wall carbohydrate composition analysis of S. mutans wild type (WT), 
ΔrmlB, ΔrmlC, ΔrmlB + pGB(_Y159F), and ΔrmlC + pGC(_H76N/K82A). Rha, rhamnose; GlcNAc, N-acetylglucosamine; Glu, glucose.
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identified in this study were water insoluble and were 
therefore dissolved in DMSO, except Ri07, which was 
already liquid at room temperature. GAS is tolerant to 
DMSO concentrations of 2%, therefore this was the 
maximum concentration used in bacterial assays. Even 
in DMSO, Ri04 and Ri07 were highly insoluble in bac-
terial culture medium and could therefore not be tested 
for inhibition of bacterial growth. The remaining five frag-
ments were soluble at the highest concentration tested 
and were able to inhibit growth of GAS with IC50 values 
ranging from 110 µM to 2.67 mM (Fig. 6A, Table 1). Since 
Ri03 and Ri06 were most active against GAS, we contin-
ued with these two fragments. In accordance with growth 
inhibition, GAS morphology was also severely affected 
upon exposure to either 200 µM Ri03 or 100 µM Ri06 
(Fig. 6C). Especially for Ri03, streptococci were swollen 
and chains were longer, a phenotype reminiscent of an 
inducible gacA GAS knockout strain (van der Beek et al., 
2015).
The fragments that were identified here may not be 
completely specific for inhibition of dTDP-L-rhamnose 
since they generally have lower affinity. To assess poten-
tial off-target effects, we incubated Ri03 and Ri06 with 
Staphylococcus aureus USA300 NRS384, a pathogenic 
methicillin-resistant bacterium that lacks expression of 
rhamnose. Ri03 and Ri06 killed S. aureus with an IC50 
~ 2.48 mM and 440 µM, respectively (Fig. 6B), suggest-
ing that the observed growth inhibition is due to off-target 
effects. However, the approximately 20-fold window in IC50 
for Ri03 against GAS compared to S. aureus suggested 
that growth inhibition could be at least partially dependent 
on inhibition of dTDP-L-rhamnose biosynthesis pathway. 
To confirm this, we used a biochemical assay in which 
recombinant RmlB, RmlC and GacA form dTDP-L-rham-
nose out of the substrate dTDP-L-glucose (van der Beek 
et al., 2015). Ri03 showed a concentration-dependent 
inhibition of dTDP-L-rhamnose formation with an IC50 ~ 
166 µM (Fig. 6D). These data suggest that Ri03 directly 
targets the dTDP-L-rhamnose biosynthesis pathway 
despite having additional off-target effects in vivo.
Activity of Ri03 against other bacterial species
We extended our experiments to include other human 
and animal streptococcal species for which dTDP-L-
rhamnose is an essential nucleotide sugar. Group C 
Streptococcus contains a related surface carbohydrate, 
the characteristic group C carbohydrate, composed of 
a polyrhamnose backbone decorated with a di-GalNAc 
side chain (Mistou et al., 2016). Ri03 inhibited growth of 
GCS with an IC50 of 0.42 mM (Fig. 6E) and of S. mutans 
with an IC50 of 0.41 mM (Fig. 6E). In addition, we also 
assessed the effect of Ri03 against M. tuberculosis, the 
causative agent of tuberculosis, for which dTDP-L-rham-
nose biosynthesis is also essential (Ma et al., 2002; Li 
et al., 2006). Again, Ri03 prevented growth of M. tubercu-
losis at a concentration of 175 µM (Fig. 6F).
Discussion
In this study, we show that GAS RmlB and RmlC are 
dTDP-glucose-4,6-dehydratase and dTDP-4-keto- 
6-deoxyglucose-3,5-epimerase enzymes respectively. Fig. 5. Screening and fragment validation flowchart.
Table 1. Overview of identified compounds and IC50 for GAS growth inhibition
Inhibitor Compound Binding target IC50 (mM) GAS
Ri01 N-(1-Naphthyl)ethylenediamine dihydrochloride RmlB, RmlC, GacA 0.27
Ri02 2,5-Difluorophenylhydrazine RmlB, GacA 0.27
Ri03 5-(4-chlorophenyl)-2-furoic acid RmlB, RmlC, GacA 0.12
Ri06 4,4’-Thiodiphenol RmlB, GacA 0.11
Ri08 2-(2,5-Dimethyl-1H-pyrrol-1-yl) benzoic acid RmlB, RmlC 2.67
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Fig. 6. Fragment Ri03 inhibits dTDP-L-rhamnose biosynthesis in vitro and growth of streptococci and M. tuberculosis in vivo.  
A. Dose–response curves for growth inhibition of GAS with various concentrations of Ri01, Ri02, Ri03, Ri06 or Ri08. IC50 values range from 
110 µM to 2.67 mM.  
B. Dose–response curves for growth inhibition of rhamnose-deficient S. aureus with various concentrations of Ri03 and Ri06. IC50 values 
range are 2.48 mM and 440 µM respectively.  
C. Representative scanning electron microscopy images of GAS after 16 h incubation in growth medium (THY), or THY with the addition of 
1% DMSO, 0.2 mM Ri03 or 0.1 mM Ri06.  
D. Dose-dependent inhibition of dTDP-L-rhamnose biosynthesis using recombinant RmlB, C and GacA in a biochemical assay. The assay 
was initiated by the addition of 400 µM dTDP-D-glucose and conversion was measured through oxidation of NADPH to NADP+ at 340 nm. 
Background absorbance was subtracted and IC50 value was determined using the nonlinear fit model  
E. Dose–response curves for growth inhibition of S. equi subsp. zooepidemicus (Group C Streptococcus; GCS) and S. mutans with various 
concentrations of Ri03. IC50 values are 420 µM and 410 µM respectively.  
F. Ri03 prevents growth of M. tuberculosis with a minimal inhibitory concentration of 175 µM using an agar-based spot culture growth 
inhibition assay. Dose–response curves represent mean ± SEM of at least three biological experiments performed in duplicate, except for M. 
tuberculosis MIC, which was performed twice.
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Both GAS RmlB and RmlC functionally replaced S. 
mutans homologs in a heterologous expression system. 
The rescue of growth and morphological phenotypes 
of the rmlB and rmlC mutants by plasmid overexpres-
sion excludes the occurrence of polar effects within the 
rmlACB operon. In addition to proving the function of 
both GAS RmlB and RmlC as rhamnose biosynthesis 
enzymes, we also identified Y159 in RmlB and H76 and 
K82 in RmlC as critical catalytic residues. Our comple-
mentation studies indicate that the mechanism of catal-
ysis is conserved among streptococcal species.
Deletion of rmlB and rmlC in S. mutans resulted in a 
phenotype similar as previously observed for an rmlD 
deletion mutant (van der Beek et al., 2015), underscor-
ing that inhibition of the dTDP-rhamnose biosynthesis 
pathway severely impacts bacterial viability. Indeed, 
the rmlABCD genes are essential for S. mutans in the 
competitive environment of a mutant transposon library 
(Shields et al., 2018), similar to GAS and GCS (Le 
Breton et al., 2013; 2015; Charbonneau et al., 2017). 
We are however able to construct rml deletion mutants 
in S. mutans in isolation in contrast to similar attempts 
in GAS (van Sorge et al., 2014). The reason for this dis-
crepancy is currently unclear but may be caused by dif-
ferential compositions of the cell walls or possibly these 
deletions are partially rescued through unidentified 
interacting pathways.
Screening a chemical compound library to identify 
inhibitors of the dTDP-L-rhamnose biosynthesis path-
way is methodically challenging. Previously, indirect 
methods were used to determine the production of the 
end product dTDP-L-rhamnose by monitoring the pro-
duction of co-factor NAD(P)H (Graninger et al., 1999; 
Sivendran et al., 2010; van der Beek et al., 2015). A 
superior assay would involve a HPLC or mass spec-
trometry approach where every single step of prod-
uct formation and substrate consumption could be 
monitored. However, it is challenging to develop this 
method for medium or high throughput screening. We, 
therefore, investigated an approach using recombinant 
enzymes in their natural state, i.e. with bound co-factors 
in their active site. RmlB enzymes require the co-fac-
tors NAD(P), which appears to be tightly bound in the 
active site as it was co-purified during RmlB crystalli-
zations (Allard et al., 2002; Beis et al., 2003). This is 
in agreement with the regeneration of NAD during 
dTDP-4-keto-6-deoxy-D-glucose synthesis (Allard 
et al., 2002). GacA/RmlD enzymes also require NADPH 
as a co-factor, which appears to be less tightly bound 
as it was not observed in the GAS GacA and S. suis 
RmlD crystal structures and therefore should be regen-
erated by a different enzyme (Blankenfeldt et al., 2002; 
van der Beek et al., 2015). Using the binding approach, 
we identified seven potential inhibitors that interacted 
with at least one enzyme of the dTDP-L-rhamnose bio-
synthesis pathway with affinities ranging from 0.1 mM 
to 80 mM. One of the most potent chemical fragments 
Ri03, 5-(4-chlorophenyl)-2-furoic acid, is a small mole-
cule, which binds RmlB and GacA with an affinity of 0.2 
and 0.3 mM, respectively, and RmlC with approximately 
3 mM. The 2-furoic acid scaffold of Ri03 is of interest 
since this organic compound is used as a preservative 
and flavoring agent in the food industry. The bactericidal 
and fungicidal activity of 2-furoic acid is presumably 
unrelated to rhamnose biosynthesis inhibition, but may 
be an explanation for the observed rhamnose-indepen-
dent inhibition of S. aureus. Previous studies have also 
identified small molecules that inhibit Rml enzymes (Ma 
et al., 2001; Babaoglu et al., 2003; Sivendran et al., 
2010; Wang et al., 2011; Ren et al., 2015). However, 
none of the predicted or confirmed inhibitors show a 
structural resemblance to Ri03.
Of particular interest is the observation that Ri03 also 
inhibits growth of M. tuberculosis. As drug-resistant tuber-
culosis continues to be a public health crisis and specif-
ically multi- and extensively drug-resistant tuberculosis 
cure rates are below 60 and 30%, new chemical entities 
with activity against M. tuberculosis are urgently required. 
Interestingly, Ri03 has a similar chemical scaffold as 
another anti-tuberculosis compound that was recently 
reported, which has an MIC50 of 135 µM (Negatu et al., 
2018; 5-(4-Chlorophenyl)-N,N,2-trimethyl-3-furamide, 
compound F8). It is unknown whether F8 targets the 
dTDP-L-rhamnose biosynthesis pathway, but this is cer-
tainly something that should be investigated. If F8 also 
was inhibiting the dTDP-rhamnose biosynthesis pathway, 
these lead structures together with available structural 
and biochemical information on enzymes of the rham-
nose biosynthesis pathway, should guide future attempts 
for rational drug design to optimize specificity as well as 
solubility of Ri03 and F8.
Fragments such as the ones that we identified here, 
are generally known to have low affinity and limited spec-
ificity. Indeed, using a bacterial species which does not 
synthesize rhamnose (S. aureus), we observed that Ri03 
has off-target effects that attenuated bacterial growth. 
Nonetheless, Ri03 is approximately 10- to 20-fold more 
effective at inhibiting growth of species for which rham-
nose is essential, i.e. three streptococcal species as well 
as M. tuberculosis. The high sequence identity of RmlB, 
RmlC and GacA/RmlD among GAS, GCS and S. mutans 
(92–94%, 83% and 82–87% protein sequence iden-
tity respectively; Fig. 2C) supports the observation that 
Ri03 shows similar IC50 values against all three strains. 
For M. tuberculosis, protein sequence identity is less 
apparent and highest for RmlB (61%, 30% and 35% for 
RmlB, RmlC and GacA respectively). This may indicate 
that the observed mycobacterial growth inhibition of Ri03 
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predominantly occurs through interference with RmlB 
function, which coincides with the fact that Ri03 has the 
highest affinity for this rhamnose biosynthesis enzyme. 
Complementary, we have proven that Ri03 acts specif-
ically on the dTDP-L-rhamnose biosynthesis pathway 
using a biochemical assay.
Future experiments aim to investigate the binding mode 
of Ri03 on a structural level to the proteins RmlB, RmlC 
and GacA to elucidate whether Ri03 inhibits RmlB, RmlC 
and GacA by competing with the nucleotide-sugar and if 
a common binding mode is observed among the different 
enzymes. With more functional and structural knowledge, 
Ri03 can be further optimized to identify more potent 
and specific derivatives with greater potency targeting 
the GAS and related homologous Rml enzymes in other 
pathogenic species.
Experimental procedures
Bacterial strains and growth conditions
Bacterial strains used in this study are described in Table 2. 
S. mutans Xc (Koga et al., 1989), a serotype c wild-type 
(WT) strain, was a kind gift of Dr. Y. Yamashita (Kyushu 
University, Japan) and was routinely grown in Todd-Hewitt 
Broth (THB, Oxoid) or on THB agar at 37°C with 5% CO2. 
When appropriate, S. mutans was cultured with 10 µg ml−1 
erythromycin (ERY) or 3 µg/ml chloramphenicol (CHL). 
GAS 5448, a representative of the epidemic M1T1 clone, 
was cultured in Todd-Hewitt Broth (Becton Dickinson) sup-
plemented with 1% yeast extract (THY; Oxoid) or on THY 
agar at 37°C. E. coli MC1061 was used for cloning pur-
poses and was grown in lysogeny broth (LB, Oxoid) or on 
LB agar containing 10 µg/ml CHL at 37°C. Mycobacterium 
tuberculosis laboratory strain H37Rv was routinely cultured 
in Middlebrook 7H9 broth (Difco) supplemented with 10% 
(v/v) Albumin Dextrose Catalase (ADC) enrichment (Difco), 
0.05% (v/v) tyloxapol and 0.02% (v/v) glycerol. Liquid 
cultures were grown at 37°C in 50 mL centrifugation tubes 
with rotation of 40 rpm until mid-exponential phase (OD600 
~ 1). For solid growth drug susceptibility experiments, M. 
tuberculosis H37Rv was grown in Middlebrook 7H10 (Difco) 
agar medium supplemented with 10% (v/v) of Oleic acid 
ADC enrichment (OADC) (Difco) and 0.5% (v/v) glycerol 
(c7H10) at 37°C incubator.
Cloning, expression and purification of GAS enzymes 
and biochemical assay
GAS RmlB, RmlC and GacA proteins were produced and 
purified as described previously (van der Beek et al., 2015). 
The IC50 of Ri03 against the dTDP-rhamnose biosynthesis 
pathway enzymes RmlB, RmlC and GacA was determined 
using the published procedure (van der Beek et al., 2015). In 
short, the assay buffer system contained 25 mM Tris-base 
(pH 7.5), 150 mM NaCl, 0.2 mM NADPH and 5 pM of recom-
binant GAS RmlB, RmlC and GacA. The assay was started 
with the addition of 400 µM dTDP-D-glucose. The oxida-
tion of NADPH to NADP+ was measured by the change 
in intrinsic absorbance at 340 nm using a SpectraMax M2 
plate reader. Background absorbance was subtracted and 
IC50 value was determined using the nonlinear fit model in 
GraphPad Prism.
Genetic manipulation of S. mutans
Streptococcus mutans is naturally competent and was trans-
formed as described previously. Shortly, bacteria were grown 
in THB containing 5% heat-inactivated horse serum (BioRad) 
and supplied with 500 ng knockout construct or complemen-
tation plasmid (van der Beek et al., 2015). Cultures were 
plated on THB agar plates containing the appropriate antibi-
otics. Single colonies were selected and verified for the dele-
tion of rmlB/rmlC and/or the presence of complementation 
plasmid using colony PCR and sequencing.
Deletion mutants of rmlB (SMU ΔrmlB) and rmlC (SMU 
ΔrmlC) were obtained via the addition of a knockout construct 
Table 2. Bacterial strains used in this study
Bacterial strains Abbreviation Resistance
S. mutans Xc wild type (serotype c) SMU WT –
S. mutans Xc ΔrmlB SMU ΔrmlB ERY
S. mutans Xc ΔrmlB + pDC123_SMU_rmlB SMU ΔrmlB + pSB ERY + CHL
S. mutans Xc ΔrmlB + pDC123_GAS_rmlB SMU ΔrmlB + pGB ERY + CHL
S. mutans Xc ΔrmlB + pDC123_GAS_rmlB_Y159F SMU ΔrmlB + pGB_Y159F ERY + CHL
S. mutans Xc ΔrmlC SMU ΔrmlC ERY
S. mutans Xc ΔrmlC + pDC123_SMU_rmlC SMU ΔrmlC + pSC ERY + CHL
S. mutans Xc ΔrmlC + pDC123_GAS_rmlC SMU ΔrmlC + pGC ERY + CHL
S. mutans Xc ΔrmlC + pDC123_GAS_rmlC_H76N SMU ΔrmlC + pGC_H76N ERY + CHL
S. mutans Xc ΔrmlC + pDC123_GAS_rmlC_K82A SMU ΔrmlC + pGC_K82A ERY + CHL
S. pyogenes 5448 wild type (serotype M1T1) GAS –
S. equi subsp. zooepidemicus MGCS10565 GCS –
E. coli MC1061 – –
E. coli BL21 (DE3) – –
E. coli DH5alpha – –
Staphylococcus aureus NRS384 – MRSA
M. tuberculosis H37Rv – –
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to competent S. mutans WT. This construct consisted of an 
ERY resistance cassette with ~700 bp flanking regions 
homologous to the up- and downstream regions of rmlB or 
rmlC. A detailed cloning strategy is available in the supple-
mental material and Table S1.
S. mutans complementation plasmids
S. mutans rmlB/rmlC and GAS rmlB/rmlC were amplified 
from gDNA using primers containing XbaI, XhoI or BamHI 
restriction site (Table S1). Digested PCR products were 
subsequently ligated into expression plasmid pDC123 and 
propagated in E. coli MC1061 to obtain large quantities of 
complementation plasmid. Point mutations were introduced 
by mutagenesis PCR, using overlapping primers with the 
corresponding mutation site integrated. The constructed 
plasmids with the single point mutations were all confirmed 
by DNA sequencing.
SMU ΔrmlB and SMU ΔrmlC knockout mutants were not 
transformable likely resulting from the severe growth defects. 
Therefore, SMU ΔrmlB and SMU ΔrmlC strains comple-
mented with S. mutans rmlB/rmlC or GAS rmlB/rmlC were 
constructed using a two-step approach. First, S. mutans 
WT was transformed with the complementation plasmid as 
described above. Next, these complemented strains were 
transformed with the respective rmlB or rmlC knockout con-
structs and selected for double antibiotic resistance.
Scanning Electron Microscopy
Scanning electron microscopy was performed as described 
previously by van der Beek et al. (2015). In short, bacteria 
were grown to mid-exponential phase, except when incu-
bated with rhamnose inhibitor. In this case, bacteria were 
cultured as described below in bacterial growth inhibition 
assays and grown overnight. Bacteria were subsequently 
washed, fixed, dehydrated, mounted onto 12.5 mm speci-
men stubs (Agar scientific, Stansted, Essex, UK) and coated 
with gold to 1 nm using a Quorum Q150R S sputter coater at 
20 mA. Samples were visualized with a Phenom PRO desk-
top scanning electron microscope (Phenom-World BV) at an 
acceleration voltage of 10 kV.
S. mutans growth curves
Overnight cultures of S. mutans strains with an optical den-
sity at 600 nm (OD600) higher than 0.35 were diluted 10 times 
and grown for 1.5 h to early exponential phase. Cultures were 
then diluted to OD600 0.03 and OD600 was measured manu-
ally every 30 min. For cultures with an overnight OD600 below 
0.35, the initial 10-fold dilution and growth step was omitted. 
Instead, such overnight cultures were directly diluted to OD600 
0.03 and OD600 was measured every hour. All cultures were 
incubated at 37°C with 5% CO2 in between measurements.
Cell wall carbohydrate composition analysis
Cell wall polysaccharides were isolated from S. mutans, 
hydrolyzed and analyzed by chromatography as described 
previously by van der Beek et al. (2015). In short, bacte-
rial cells were harvested from 2 to 5 L cultures and dis-
rupted in 0.1 M citrate buffer (pH 4.6) using a bead beater 
(Biospec). Cell walls were collected by centrifugation and 
boiled for 1 h at 100°C in 0.1 M sodium acetate (pH 4.6) 
containing 4% sodium dodecyl sulfate. Samples were sub-
sequently treated with RNase, DNase, pronase E and tryp-
sin. Cell walls containing peptidoglycan and the serotype C 
carbohydrate were lyophilized before hydrolysis with TFA. 
Finally, carbohydrate analysis of monosaccharides was 
performed on a Dionex ICS-3000 Ion Chromatography 
System (Dionex/Thermo Scientific) using a CarboPac PA20 
(Dionex/Thermo Scientific) 3 × 150 mm column, equipped 
with a ICS-3000 Electrochemical Detector (Dionex/Thermo 
Scientific). Monosaccharides from all samples were eluted 
from the column with 12% 0.2 M NaOH, except for mono-
saccharides from SMU ΔrmlB and ΔrmlC, which were eluted 
with 8% 0.2 M NaOH. The ‘Carbohydrates (Standard Quad)’ 
waveform was used for detection.
BLI screen using recombinant RmlB, RmlC and GacA
The Maybridge library of fragment-like molecules (Ro3) was 
purchased from Maybridge (USA). All three GAS proteins, 
RmlB, RmlC and GacA, were screened against the library 
using identical protocols. Proteins were biotinylated on primary 
amine amino acid side chains using the Thermo ScientificTM 
EZ-LinkTM NHS-PEG4-Biotin reagent. The enzymes were 
incubated with NHS-PEG4-Biotin in a 1:1 molar ratio at 150 µM 
for 45 min at room temperature. The reaction buffer contained 
25 mM HEPES, pH 7.5, 150 mM NaCl and 0.02 mM TCEP. 
Excess NHS-PEG4-biotin reagent was removed using 2 mL 
Zeba desalting spin columns (Thermo Scientific). Successful 
biotinylation on primary amines was investigated via Western 
blotting and probing with ExtrAvidin®−Peroxidase anti-
body, 1:10,000 (Sigma E2886, Fig. S1A). Before compound 
screening, the proteins were loaded onto a parallel set of 
superstreptavidin biosensors (SSA) by incubation in buffer 
for 900 s. Protein concentrations suitable for the experiments 
were determined in a series of dilutions. Final screening was 
conducted at concentrations of: 50 µg/mL RmlB, 25 µg/mL 
RmlC and 12.5 µg/mL GacA. All compounds were at 2% 
DMSO concentration. The sensor was blocked by immersion 
in biocytin (10 µg/mL) for 30 s.
Initial library screening was performed at a compound 
concentration of 200 µM. Hits were identified by plotting the 
response rate of every single compound after background 
subtraction. In total, 12 compounds were validated in 6-point 
concentration series using threefold dilutions, ranging from 
670 µM to 3 µM. Data were processed and kinetic parameters 
were calculate using the ForteBio software. Binding curves 
were manually inspected and approximate binding constants 
KD are listed in Table S3. Fragments that did not induce con-
centration-dependent signal changes, i.e. did not bind to the 
recombinant enzymes, are not displayed in Fig. S2.
Bactericidal activity
GAS 5448, GCS MGCS10565 and S. mutans Xc strains 
(Table 2) were grown in appropriate bacterial culture broth 
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overnight at 37°C. Bacterial cultures were diluted 10 times 
and grown to mid-log phase (OD600 0.4). Cultures were 
diluted 200 times in culture medium followed by a twofold 
dilution with various concentrations of rhamnose inhibitor or 
DMSO. OD600 was recorded every 15 min at 37°C with 5 sec 
medium shaking before measurement for GAS, GCS and S. 
mutans using either a Bioscreen C MBR machine (Growth 
Curves AB Ltd, Oy, Finland) or a Synergy 2 plate reader 
(Biotek). OD600 values were plotted against the concentra-
tion of compound after 9 h of growth using GraphPad Prism 
7. IC50 values were calculated using a nonlinear four-pa-
rameter dose–response curve with variable slope. Because 
high concentrations were not always feasible due to solubil-
ity issues, a high concentration of compound (50 mM) was 
artificially introduced where appropriate and set to zero to 
obtain more reliable dose–response curves.
Minimum inhibitory concentration assay in  
M. tuberculosis
To determine the effect of inhibitors of rhamnose biosynthesis 
against M. tuberculosis, we performed an agar-based spot 
culture growth inhibition assay (Evangelopoulos and Bhakta, 
2010). Briefly, compound Ri03 was dissolved in DMSO at 
20 mM concentration and serial dilutions (800 µM to 12.5 µM) 
was added in each well of a 24-well plate, followed by the addi-
tion of 2 mL of warm (55°C) c7H10 agar media. Once solid, 
the plates were inoculated with a diluted culture of M. tuber-
culosis H37Rv so that a spot (2 µL) of around 1000 CFUs was 
placed in the middle of each well. The plates were incubated 
at 37°C incubator for 14 days and the MIC99 was determined 
as the well with the lowest concentration of Ri03 where there 
was no bacteria growth. Rifampicin (a first line drugs against 
tuberculosis) was also used in parallel as control. The con-
centration of DMSO (0.1% v/v) remained constant in all wells, 
including the no drug control wells. Two independent experi-
ments were performed for MIC determination.
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